# A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty

> **NCT06284941** · NA · COMPLETED · sponsor: **Wang wanxia** · enrollment: 90 (actual)

## Conditions studied

- Femoral Neck Disease

## Interventions

- **DRUG:** Ropivacaine combined with methylene blue for iliac fascia block

## Key facts

- **NCT ID:** NCT06284941
- **Lead sponsor:** Wang wanxia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-20
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06284941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06284941, "A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06284941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*